510(k) K022053
K022053 is an FDA 510(k) premarket notification submitted by Sebia for the device "HYDRAGEL 7 LIPOPROTEIN(E), PN 4114 & HYDRAGEL LIPOPROTEIN(E) 15/30 PN 4134". The FDA issued a decision of Substantially Equivalent on Jul 12, 2002. The device falls under product code JHO (Electrophoretic Separation, Lipoproteins), a Class I device regulated under 21 CFR 862.1475. Sebia has 33 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 12, 2002
- Date Received
- Jun 24, 2002
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Electrophoretic Separation, Lipoproteins
- Device Class
- Class I
- Regulation Number
- 862.1475
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Sebia? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.